StockData
AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31

ASCENTAGE PHARMA GROUP INTERNATIONAL

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$15.36−0.01 (-0.07%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Ascentage Pharma Group International has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Ascentage Pharma Group International filed with the SEC